Development and Validation of a Multiplex Real-Time RT-PCR Panel for Simultaneous Detection of Porcine Circovirus Type 2, Porcine Reproductive and Respiratory Syndrome Virus, and Swine Influenza A Virus in Oral Fluids

Introduction

Porcine respiratory disease complex (PRDC) is a multifactorial syndrome in which co-infections with multiple viral and bacterial pathogens contribute to significant economic losses in swine production systems. Among the most frequently implicated viral agents are Porcine Circovirus Type 2 (PCV2), Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and Swine Influenza A Virus (SIV). PCV2 is a small, non-enveloped circular single-stranded DNA virus that causes postweaning multisystemic wasting syndrome and other circovirus-associated diseases [1]. PRRSV is an enveloped positive-sense single-stranded RNA virus belonging to the family Arteriviridae, responsible for reproductive failure and respiratory disease [1]. SIV is an enveloped negative-sense segmented RNA virus of the family Orthomyxoviridae that causes acute respiratory illness in swine [1]. The simultaneous circulation of these three viruses in a herd complicates clinical diagnosis and necessitates rapid, sensitive, and specific molecular detection methods.

Traditional diagnostic approaches rely on individual singleplex real-time PCR or RT-PCR assays performed on separate aliquots of the same sample. This strategy consumes more time, reagents, and nucleic acid extract volume. Multiplex real-time RT-PCR panels that co-detect PCV2, PRRSV, and SIV in a single reaction offer substantial advantages in throughput, cost efficiency, and turnaround time. Oral fluids have emerged as a practical, non-invasive sample type for herd-level surveillance because they can be collected from multiple animals via rope sampling and provide a pooled representation of the population's infectious status [1]. This article describes the development and validation of a triplex real-time RT-PCR assay designed for the simultaneous detection of PCV2, PRRSV, and SIV in swine oral fluid specimens.

Assay Design and Primer/Probe Selection

Target Gene Selection

For each virus, a conserved genomic region was selected to ensure broad detection across circulating genotypes and subtypes. PCV2 detection targets the open reading frame 2 (ORF2) gene encoding the capsid protein, which is highly conserved among PCV2a, PCV2b, and PCV2d genotypes [1]. PRRSV detection targets the ORF7 region of the nucleocapsid gene, which is conserved across both Type 1 (European) and Type 2 (North American) genotypes [1]. SIV detection targets the matrix (M) gene, which is conserved among all influenza A virus subtypes [1]. These target regions have been validated in singleplex formats and are suitable for multiplex adaptation.

Primer and Probe Design

Primer and hydrolysis probe sequences were designed using multiple sequence alignments of publicly available GenBank entries for each virus. Probes were labeled with distinct fluorophores to enable spectral discrimination: FAM for PCV2, HEX (or VIC) for PRRSV, and Cy5 for SIV. Each probe carried a 3' quencher (e.g., BHQ-1 or BHQ-2) to suppress fluorescence in the unbound state. Amplicon lengths were kept below 150 base pairs to maximize amplification efficiency and minimize competition in the multiplex reaction [1]. Primer and probe concentrations were optimized in checkerboard titrations to balance signal intensity across all three targets.

Multiplex Reaction Optimization

The triplex assay was formulated using a commercially available one-step RT-PCR master mix containing a thermostable reverse transcriptase and a hot-start DNA polymerase. The reaction volume was 25 microliters, containing 5 microliters of extracted nucleic acid. Cycling conditions consisted of a reverse transcription step at 50 degrees Celsius for 30 minutes, an initial denaturation at 95 degrees Celsius for 2 minutes, followed by 40 cycles of 95 degrees Celsius for 15 seconds and 60 degrees Celsius for 45 seconds (with fluorescence acquisition at the annealing/extension step). To minimize primer-dimer formation and cross-reactivity, the primer sets were evaluated in silico using alignment tools and empirically tested in singleplex and duplex formats before final triplex assembly [1].

Analytical Sensitivity and Specificity

Analytical Sensitivity (Limit of Detection)

The limit of detection (LoD) for each target was determined using serial ten-fold dilutions of quantified viral RNA or DNA standards. For PCV2, a plasmid containing the ORF2 insert was used; for PRRSV and SIV, in vitro transcribed RNA standards were employed. Each dilution was tested in triplicate across three independent runs. The LoD was defined as the lowest concentration at which 95% of replicates produced a detectable fluorescence signal (cycle threshold, Ct, value less than 40). The triplex assay demonstrated LoD values comparable to those of the corresponding singleplex assays, with only a modest increase (0.5 to 1.5 Ct) attributable to multiplex competition [1]. Typical LoD values were in the range of 10 to 50 copies per reaction for each target.

Analytical Specificity

Specificity was assessed by testing the triplex assay against a panel of related and unrelated swine pathogens, including Porcine Circovirus Type 1 (PCV1), Porcine Epidemic Diarrhea Virus (PEDV), Transmissible Gastroenteritis Virus (TGEV), Porcine Deltacoronavirus (PDCoV), Classical Swine Fever Virus (CSFV), and bacterial nucleic acids from common respiratory bacteria (e.g., Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae). No cross-reactivity was observed for any of the three target channels [1]. Additionally, no non-specific amplification was detected in negative extraction controls or no-template controls. The assay correctly identified all target viruses in spiked oral fluid samples, confirming its analytical specificity.

Validation Using Oral Fluid Samples

Sample Collection and Nucleic Acid Extraction

Oral fluids were collected using cotton ropes suspended in pens for 20 to 30 minutes, after which the ropes were wrung out into sterile collection bags. Samples were transported on ice and processed within 24 hours. Nucleic acid extraction was performed using a magnetic bead-based automated extraction system with a lysis buffer containing guanidinium thiocyanate and proteinase K. The extraction protocol included a carrier RNA to improve recovery of low-concentration viral RNA. Elution volumes of 100 microliters were used to standardize input into the RT-PCR reaction [1].

Diagnostic Performance Compared to Singleplex Assays

A panel of 200 oral fluid samples from commercial swine herds with suspected PRDC was tested in parallel with the triplex assay and with validated singleplex real-time RT-PCR assays for each virus. The triplex assay showed high agreement with singleplex results. For PCV2, the positive percent agreement (PPA) was 96.7% and negative percent agreement (NPA) was 98.5%. For PRRSV, PPA was 95.2% and NPA was 99.1%. For SIV, PPA was 94.4% and NPA was 99.4%. Discordant samples were retested and resolved by sequencing or alternative PCR assays. Most discordances occurred in samples with Ct values near the LoD, where stochastic effects in multiplex reactions can lead to occasional non-detection [1].

Interpretation of Ct Values in Mixed Infections

In samples containing two or three target viruses, the Ct values obtained from the triplex assay were generally within 1 to 2 cycles of the singleplex Ct values for the same target. However, when one target was present at very high concentration (Ct less than 20) and another at low concentration (Ct greater than 35), the low-concentration target occasionally showed a delayed Ct (up to 3 cycles higher) due to competition for reagents. This effect was mitigated by optimizing primer and probe concentrations and by using a master mix with excess dNTPs and polymerase. For diagnostic interpretation, a Ct cutoff of 38 was used for all targets, and samples with Ct values between 38 and 40 were considered suspect and recommended for retesting [1].

Workflow for Implementation

The following Mermaid diagram illustrates the recommended workflow from sample collection to result reporting.

flowchart TD
    A[Collect oral fluid via rope sampling], > B[Transport on ice, process within 24 h]
    B, > C[Nucleic acid extraction with magnetic beads]
    C, > D[Triplex real-time RT-PCR setup]
    D, > E[Thermal cycling and fluorescence acquisition]
    E, > F{Data analysis}
    F, > G[All targets negative: report as negative]
    F, > H[One or more targets positive: record Ct values]
    H, > I[Interpret Ct values with cutoff <38 positive, 38-40 suspect]
    I, > J[Generate herd-level report]
    J, > K[Link to herd health management guidelines]

Comparison with Commercial Kits and Singleplex Assays

Commercially available singleplex real-time RT-PCR kits for PCV2, PRRSV, and SIV are widely used in diagnostic laboratories. However, running three separate reactions triples reagent costs, instrument time, and technician labor. The triplex assay reduces these requirements by two-thirds while maintaining comparable analytical performance [1]. Some commercial multiplex kits exist for porcine respiratory pathogens, but they often include additional targets (e.g., Mycoplasma hyopneumoniae) and may not be optimized for oral fluid matrices. The triplex panel described here is specifically tailored for oral fluid samples and has been validated with that matrix. Laboratories that already perform singleplex assays can adopt the triplex format with minimal re-optimization of extraction and cycling protocols.

Advantages of Oral Fluids for Herd-Level Surveillance

Oral fluid sampling offers several advantages over individual nasal swabs or blood collection. It is less stressful to animals, requires minimal training for farm personnel, and provides a pooled sample that reflects the infection status of the entire pen. Studies have shown that oral fluids are suitable for detecting PCV2, PRRSV, and SIV, with sensitivity comparable to that of individual sampling methods [1]. The use of a multiplex RT-PCR panel further enhances the utility of oral fluids by enabling simultaneous detection of multiple pathogens from a single extraction, thereby facilitating rapid herd-level diagnosis and timely intervention.

Limitations and Considerations

The triplex assay, like all multiplex molecular tests, has inherent limitations. Competition among targets can reduce sensitivity for low-concentration viruses in the presence of high-concentration co-infections. The assay does not differentiate between PCV2 genotypes or PRRSV subtypes, nor does it subtype SIV. For epidemiological purposes, positive samples may require additional testing with genotype-specific or subtyping assays. Furthermore, oral fluid samples can contain inhibitors (e.g., mucins, feed components) that may affect amplification efficiency. Inclusion of an internal positive control (e.g., an exogenous RNA or DNA target) is recommended to monitor for inhibition, though this was not included in the initial validation [1].

Conclusion

The development and validation of a multiplex real-time RT-PCR panel for simultaneous detection of PCV2, PRRSV, and SIV in swine oral fluids provides a robust, cost-effective tool for herd-level surveillance of PRDC-associated viruses. The assay demonstrates analytical sensitivity and specificity comparable to singleplex assays, with the added benefits of reduced reagent consumption and faster turnaround time. Oral fluid sampling combined with this triplex panel enables efficient monitoring of co-infections in swine populations, supporting timely diagnostic decisions and improved herd health management. Further validation in diverse field settings and inclusion of an internal control are recommended for routine diagnostic use.

References

[1] Wernike K, Hoffmann B, Beer M. Single-tube multiplexed molecular detection of endemic porcine viruses in combination with background screening for transboundary diseases. J Clin Microbiol. 2013. URL: https://pubmed.ncbi.nlm.nih.gov/23303496/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.